PubRank

Richard E Greenberg

Author PubWeight™ 70.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 2013 4.78
2 The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006 3.88
3 Cutaneous metastases from genitourinary malignancies. Urology 2004 2.97
4 Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 2011 2.87
5 Bladder cancer. J Natl Compr Canc Netw 2013 2.46
6 Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results. Int J Radiat Oncol Biol Phys 2011 2.23
7 Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 2011 2.22
8 Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology 2011 2.20
9 Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2005 2.08
10 Promoter hypermethylation profile of kidney cancer. Clin Cancer Res 2004 2.02
11 Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2011 1.98
12 Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology 2010 1.77
13 Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 2008 1.64
14 Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009 1.60
15 Enhancing renal masses with zero net growth during active surveillance. J Urol 2007 1.59
16 Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology 2012 1.54
17 Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology 2013 1.49
18 Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 2002 1.48
19 Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011 1.46
20 Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol 2012 1.45
21 Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int 2013 1.41
22 Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. Urology 2002 1.37
23 Bladder cancer. J Natl Compr Canc Netw 2009 1.32
24 Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int 2011 1.31
25 Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res 2004 1.22
26 Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res 2003 1.13
27 Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes. Cancer 2004 1.12
28 Predicting growth of solid renal masses under active surveillance. Urol Oncol 2008 1.11
29 Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int 2009 1.05
30 Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology 2003 1.04
31 Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions. J Urol 2012 1.01
32 Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2013 0.97
33 Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate 2007 0.96
34 Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int 2012 0.94
35 Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol 2011 0.91
36 Current concepts in penile cancer. J Natl Compr Canc Netw 2013 0.89
37 Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy. J Urol 2012 0.89
38 Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin. Urol Oncol 2012 0.88
39 Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol 2012 0.88
40 Bacillus calmette-guérin failures and beyond: contemporary management of non-muscle-invasive bladder cancer. Rev Urol 2008 0.87
41 Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. J Urol 2005 0.86
42 Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression? Cancer Genet Cytogenet 2005 0.83
43 The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician. Urol Clin North Am 2003 0.81
44 Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. J Urol 2003 0.79
45 Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol 2010 0.79
46 Is there a benefit to frozen section analysis at the time of partial nephrectomy? Can J Urol 2013 0.77
47 Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol 2011 0.76
48 Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis. Urol Oncol 2011 0.76
49 Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Urology 2008 0.75
50 Nonseminomatous germ cell tumor of the testis 9 years after a germ cell tumor of the pineal gland: case report and review of the literature. Can J Urol 2008 0.75
51 Patient reported outcomes among treatment modalities for prostate cancer. Can J Urol 2016 0.75
52 Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017 0.75